Letroz 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Sun Pharmaceutical Industries Ltd
  4. Letroz 2.5 mg Tablet

Letroz 2.5 mg Tablet

Letroz 2.5 mg Tablet contains letrozole 2.5 mg, an aromatase inhibitor used as hormone therapy for breast cancer. It is primarily used to treat hormone-sensitive breast cancer in postmenopausal women. The tablet is taken orally according to the treatment plan prescribed by a qualified healthcare professional.

BUY NOW

Category

Letrozole works by inhibiting aromatase, an enzyme involved in estrogen production, thereby lowering estrogen levels in the body. This can help slow or stop the growth of estrogen-dependent breast cancer cells. Letroz 2.5 mg is marketed by Sun Pharmaceutical Industries Ltd and is available in multiple pack presentations, including 5, 10, and 30 tablets. Treatment duration and dosage are determined by the treating physician based on the patient’s condition and therapeutic response.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Film-Coated Tablet
Therapeutic Class Aromatase Inhibitor
Route of Administration Oral
Manufacturer/Marketer Sun Pharmaceutical Industries Ltd

Product Also Known As

Letroz 2.5 mg Tablet, Letroz 2.5mg Tablet, Letrozole 2.5 mg Tablet, Letrozole 2.5mg Tablet, Letrozole Anticancer Tablet, Letrozole Breast Cancer Tablet, Aromatase Inhibitor Tablet